An Australian drug that has the potential to treat stroke survivors is under development in the UK by a UK-based biotechnology company DevCo. The drug, known as AM-36, can minimise brain damage and physical impairments caused by strokes – Australia’s leading cause of disability. Dr Jenny Callaway and her colleagues at Monash University discovered the…
Genes & Epilepsy: How do they “fit”? – Robyn Wallace Robyn has identified the first gene known to cause febrile seziures. This is a specific form of epilepsy that affects young children.
Most transplants need immunosuppressive drugs but livers often don’t . Why and how can we use this knowledge?
Fresh Science is on hold for 2022. We will be back in 2023.
Let us know if you want to receive updates about the program.
Fresh Science is a national competition and training program helping early-career researchers find and share their stories of discovery.
We take young researchers with no media experience and help them become media spokespeople for their science, and reach stakeholders in government and industry.
Fresh Science gives finalists a taste of life in the limelight, with a day of media training, a day of training in stakeholder engagement, and a public event in their home state.
Alumni of the program include Professor Allan Duffy and Dr Niraj Lal.
Read some of the fresh science we discovered in 2021 here.
